[go: up one dir, main page]

WO2002060948A1 - Nouvelle proteine recepteur couplee a une proteine g et adn correspondant - Google Patents

Nouvelle proteine recepteur couplee a une proteine g et adn correspondant Download PDF

Info

Publication number
WO2002060948A1
WO2002060948A1 PCT/JP2002/000707 JP0200707W WO02060948A1 WO 2002060948 A1 WO2002060948 A1 WO 2002060948A1 JP 0200707 W JP0200707 W JP 0200707W WO 02060948 A1 WO02060948 A1 WO 02060948A1
Authority
WO
WIPO (PCT)
Prior art keywords
protein
ligand
screening
novel
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2002/000707
Other languages
English (en)
Japanese (ja)
Inventor
Takeo Moriya
Takashi Ito
Yasushi Shintani
Nobuyuki Miyajima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of WO2002060948A1 publication Critical patent/WO2002060948A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention concerne une nouvelle protéine utile pour cribler un agoniste et/ou un antagoniste; une protéine d'origine humaine ou son sel; un ADN codant cette protéine; une méthode de détermination d'un ligand pour la protéine; une méthode de criblage et/ou une trousse de criblage permettant de détecter un composé capable d'altérer les propriétés de liaison du ligand envers la protéine; des composés obtenus à l'aide de la méthode de criblage ou des sels de ces derniers, et autres. La protéine d'origine humaine ou l'ADN codant cette dernière peuvent être utilisés pour: (1) déterminer un ligand pour la protéine; (2) préparer des prophylactiques et/ou des médicaments pour des maladies associées à l'hypofonction de ladite protéine; (3) cribler un composé (un agoniste, un antagoniste ou autre) capable d'altérer les propriétés de liaison de la protéine selon l'invention envers le ligand, et autres.
PCT/JP2002/000707 2001-01-31 2002-01-30 Nouvelle proteine recepteur couplee a une proteine g et adn correspondant Ceased WO2002060948A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2001024193 2001-01-31
JP2001-24193 2001-01-31
JP2001065292 2001-03-08
JP2001-65292 2001-03-08

Publications (1)

Publication Number Publication Date
WO2002060948A1 true WO2002060948A1 (fr) 2002-08-08

Family

ID=26608674

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/000707 Ceased WO2002060948A1 (fr) 2001-01-31 2002-01-30 Nouvelle proteine recepteur couplee a une proteine g et adn correspondant

Country Status (1)

Country Link
WO (1) WO2002060948A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001077330A2 (fr) * 2000-04-06 2001-10-18 Pharmacia & Upjohn Company Recepteurs couples a une proteine g
DE10019120A1 (de) * 2000-04-18 2001-10-25 Michael Brues PAFR2:gen, cDNA, Expression, Aminosäuresequenz
WO2001098351A2 (fr) * 2000-06-16 2001-12-27 Incyte Genomics, Inc. Recepteurs couples a la proteine g

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001077330A2 (fr) * 2000-04-06 2001-10-18 Pharmacia & Upjohn Company Recepteurs couples a une proteine g
DE10019120A1 (de) * 2000-04-18 2001-10-25 Michael Brues PAFR2:gen, cDNA, Expression, Aminosäuresequenz
WO2001098351A2 (fr) * 2000-06-16 2001-12-27 Incyte Genomics, Inc. Recepteurs couples a la proteine g

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KUNZ, D. ET AL.: "The human leukocyte platelet-activating factor receptor. cDNA cloning, cell surface expression and construction of a novel epitope-bearing analog", J. BIOL. CHEM., vol. 267, no. 13, 1992, pages 9101 - 9106, XP002951003 *

Similar Documents

Publication Publication Date Title
WO2002084286A1 (fr) Procede de criblage
WO2003093269A3 (fr) Pyrazolopyrimidine-4-one substituee
WO1999048523A3 (fr) Antagonistes de mediateurs inflammatoires
WO2003087304A3 (fr) Hetero-aryles tri-substitues et procedes de fabrication
WO2004082623A3 (fr) Composes piperidine substituee
WO2001077172A3 (fr) Recepteurs connus couples a la proteine g non endogenes a activation constitutive
AU2003237508A1 (en) Determining fluid composition from fluid properties
DE60217147D1 (de) Lactamderivaten zur verwendung als humane 11cby rezeptorantagonisten
WO2003047520A3 (fr) Inhibiteurs de facteur xa a aminomethyle substitue
EP1398029A8 (fr) Derivés de pyrazole,substitués en position 3 ayant une affinité envers le NR3B1 récepteur
WO2004112704A3 (fr) Composes de piperidine substitues et procedes d'utilisation associes
WO2006131659A3 (fr) Compositions de liant rapide pour pieces et ouvrages en beton contenant un sel de calcium
WO2005033066A3 (fr) Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique sanofi-synthelabo
WO2002044368A1 (fr) Nouvelles proteines du recepteur couple a la proteine g et leurs adn
WO2003002604A3 (fr) Nouveaux recepteurs couples a la proteine g et leurs sequences d'adn
WO2003018798A3 (fr) Recepteur couple aux proteines g nouvellement identifie et sequences d'adn de ce recepteur
WO2004094400A3 (fr) Benzopyranes substitues en tant qu'agonistes selectifs du recepteur beta de l'oestrogene
WO2002060948A1 (fr) Nouvelle proteine recepteur couplee a une proteine g et adn correspondant
WO2002004624A9 (fr) Nouvelle proteine receptrice couplee a la proteine g et adn destine a celle-ci
WO2002061075A1 (fr) Proteine de recepteur couple aux proteines g et adn correspondant
WO2003012104A1 (fr) Nouvelle proteine de recepteurs couples aux proteines g et adn de celle-ci
WO2003008445A1 (fr) Nouvelle proteine receptrice couplee a la proteine g, et adn codant pour elle
WO2010033868A3 (fr) Composés spécifiques d'un ligand qui ne sont pas des anticorps et qui inhibent l'activation de cr2 et procédés pour les utiliser
EP1255109A4 (fr) Procede de criblage
DE602004031355D1 (de) Neue 1,3-disubstituierte azetidinderivate zur verwendung als liganden des 5ht2a-rezeptors

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP